PAPP, K.; LEBWOHL, M.; GOTTLIEB, A.; SEBASTIAN, M.; LANGLEY, R.; OKUBO, Y.; WANG, M.; CIOFFI, C.; STAELENS, F.; REICH, K. Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis with Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the BE VIVID Phase 3 Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s18, 2021. DOI: 10.25251/skin.5.supp.18. Disponível em: https://jofskin.org/index.php/skin/article/view/1171. Acesso em: 3 jul. 2024.